Alexandra Ellervik
Investor Relations Kontakt bei CHOSA ONCOLOGY AB
Profil
Alexandra Ellervik is currently the Head of Communication & Investor Relations at Chosa Oncology AB.
Previously, she worked as an Investor Relations & Press Contact at RhoVac AB.
Aktive Positionen von Alexandra Ellervik
| Unternehmen | Position | Beginn |
|---|---|---|
| CHOSA ONCOLOGY AB | Investor Relations Kontakt | - |
Ehemalige bekannte Positionen von Alexandra Ellervik
| Unternehmen | Position | Ende |
|---|---|---|
| CHOSA ONCOLOGY AB | Investor Relations Kontakt | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CHOSA ONCOLOGY AB | Commercial Services |
| Private Unternehmen | 1 |
|---|---|
RhoVac AB
 RhoVac AB BiotechnologyHealth Technology RhoVac AB opertaes as biotechnology company that engages in the research and development of immunotherapy. The firm develops therapeutic cancer vaccines. Its main focus is the development of a drug with the potential to prevent or limit the metastasis of metastatic cancers. The company was founded by Bo Anders Ljungqvist, Per Thor Straten, and Mads Hald Andersen in November 2015 and is headquartered in Lund, Sweden. | Health Technology |
